title: Adalimumab for recurrent orbital myositis in Crohn's disease: report of a case with a 3-year follow-up.
authors.forename: María-Luisa
authors.initials: ML
authors.lastname: Hernández-Garfella
authors.forename: Alicia
authors.initials: A
authors.lastname: Gracia-García
authors.forename: Enrique
authors.initials: E
authors.lastname: Cervera-Taulet
authors.forename: Carolina
authors.initials: C
authors.lastname: García-Villanueva
authors.forename: Javier
authors.initials: J
authors.lastname: Montero-Hernández
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D055622:Orbital Myositis / Q000150:complications / Q000188:drug therapy*; D012008:Recurrence
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab